-
recombinant therapeutic protein, and
living medicines used in cell therapy.
Biologics can be
composed of sugars, proteins,
nucleic acids, or
complex combinations...
- 2020. "Samsung
BioLogics annual sales up 30% on
contract research growth".
Korea Biomedical Review. 23
January 2020. "Samsung
Biologics to add new contract...
- for
biologics drug development. WuXi
Biologics'
roots date back to 2010, and
began building out
capabilities and
facilities required for
biologics discovery...
- countries,
including the
United States and Europe. It also
manufactures novel biologics as well as
biosimilar insulins and antibodies,
which are sold in India...
- A
biologics license application (BLA) is
defined by the U.S. Food and Drug
Administration (FDA) as follows: The
biologics license application is a request...
- Heat
Biologics Inc. is a U.S.
biotechnology company focused on the
field of immunotherapy. Heat
Biologics was
founded by Jeff Wolf and
Eckhard Podack,...
- The
Center for
Biologics Evaluation and
Research (CBER) is one of six main
centers for the U.S. Food and Drug
Administration (FDA),
which is a part of...
-
AbCellera Biologics Inc. is a Vancouver,
British Columbia-based
biotechnology firm that
researches and
develops human antibodies. The
company is best...
- 5430
CanSino Biologics (simplified Chinese: 康希诺生物;
traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò Shēngwù),
often abbreviated as CanSino
BIO, is a Chinese...
- approval.
Unlike with
generic drugs of the more
common small-molecule type,
biologics generally exhibit high
molecular complexity and may be
quite sensitive...
